Large-scale testing (Phase 3)Study completedNCT01110902
What this trial is testing
Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)
Who this might be right for
Major Depressive Disorder
Novartis Pharmaceuticals 589